Development of Buffalo Hump in the course of antiretroviral therapy including raltegravir and unboosted atazanavir: a case report and review of the literature

INTRODUCTION: The availability of raltegravir plus atazanavir provides an alternative antiretroviral strategy that may be equally efficacious and less toxic than those currently recommended in HIV treatment guidelines. In fact, this new combination antiretroviral therapy attracts the attention of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Ceccarelli, Giancarlo, d'Ettorre, Gabriella, Marchetti, Francesco, Rizza, Cecilia, Mastroianni, Claudio M, Carlesimo, Bruno, Vullo, Vincenzo
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3047431/
https://www.ncbi.nlm.nih.gov/pubmed/21329500
http://dx.doi.org/10.1186/1752-1947-5-70

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3047431/
https://www.ncbi.nlm.nih.gov/pubmed/21329500
http://dx.doi.org/10.1186/1752-1947-5-70

Ejemplares similares